Sign In
Buy KRYS
$301.82
+8.61 (+2.94%)
At Close: Jun 03, 2026
Strength Seen in Krystal Biotech (KRYS): Can Its 4.2% Jump Turn into More Strength?
10:56am, Wednesday, 25'th Jun 2025
Krystal Biotech (KRYS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near t
Intra-patient, double-blind, multicenter, placebo-controlled study with crossover design Repeat administration under compassionate use was previously shown to be well tolerated and associated with ful
Why Is Krystal Biotech (KRYS) Down 3.5% Since Last Earnings Report?
12:36pm, Thursday, 05'th Jun 2025
Krystal Biotech (KRYS) reported earnings 30 days ago. What's next for the stock?
Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn't Ignore
08:30am, Wednesday, 14'th May 2025
Investors searching for high-quality opportunities in the pharmaceutical space should keep a close eye on stocks trading at extremely oversold levels. One of the most popular ways to measure this is
Krystal Biotech to Present at BofA Securities 2025 Health Care Conference
08:00am, Wednesday, 07'th May 2025
PITTSBURGH, May 07, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc . (the “Company”) (NASDAQ: KRYS) today announced that the Company will participate in the BofA Securities 2025 Health Care Confere
Krystal Biotech, Inc. (KRYS) Q1 2025 Earnings Call Transcript
02:43pm, Tuesday, 06'th May 2025
Krystal Biotech, Inc. (NASDAQ:KRYS ) Q1 2025 Earnings Conference Call May 6, 2025 8:30 AM ET Company Participants Stephane Paquette - VP, Corporate Development Krish Krishnan - Chairman and CEO Suma K
Krystal Biotech Q1 Earnings and Sales Miss Estimates, Stock Down
02:40pm, Tuesday, 06'th May 2025
KRYS reports disappointing first-quarter 2025 results, with both earnings and sales missing estimates. Shares down.
Krystal Biotech, Inc. (KRYS) Misses Q1 Earnings and Revenue Estimates
10:15am, Tuesday, 06'th May 2025
Krystal Biotech, Inc. (KRYS) came out with quarterly earnings of $1.20 per share, missing the Zacks Consensus Estimate of $1.38 per share. This compares to earnings of $0.03 per share a year ago.
Krystal Biotech, Inc. (KRYS) Earnings Expected to Grow: Should You Buy?
11:06am, Tuesday, 29'th Apr 2025
Krystal Biotech (KRYS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Krystal Biotech Announces European Commission Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
07:00am, Monday, 28'th Apr 2025
VYJUVEK approved for the treatment of DEB from birth in Europe Approval allows for dosing at home or in a healthcare setting, as well as patient or caregiver administration if deemed appropriate by a
Jeune Aesthetics Appoints Marc Forth as Chief Executive Officer
04:30pm, Monday, 07'th Apr 2025
PITTSBURGH, April 07, 2025 (GLOBE NEWSWIRE) -- Jeune Aesthetics, Inc. (“Jeune”), a wholly owned subsidiary of Krystal Biotech, Inc. (“Krystal”) (NASDAQ: KRYS) leveraging Krystal's clinically v
5 Biotech Stocks Worth Adding Amid Global Uncertainty in 2025
02:25pm, Monday, 07'th Apr 2025
New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry despite the uncertain macroeconomic environment. A strong portfolio and soli
Krystal Biotech: Preparing To Chase Following Positive CHMP Opinion For VYJUVEK
08:30am, Monday, 24'th Mar 2025
Krystal Biotech's VYJUVEK, a first-mover gene therapy for DEB, has received a positive CHMP recommendation, potentially boosting its global market presence and valuation. Despite KRYS's premium valuat
Krystal Biotech (KRYS) Up 3.3% Since Last Earnings Report: Can It Continue?
12:36pm, Friday, 21'st Mar 2025
Krystal Biotech (KRYS) reported earnings 30 days ago. What's next for the stock?
Here's Why Krystal Biotech, Inc. (KRYS) is a Strong Momentum Stock
10:50am, Monday, 17'th Mar 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
